<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2017-8-64-67</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-1826</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Практика</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Practice</subject></subj-group></article-categories><title-group><article-title>ЭФФЕКТИВНОСТЬ КОМПЛЕКСНОГО ЛЕЧЕНИЯ БОЛЬНЫХ ОСТРОЙ СЕНСОНЕВРАЛЬНОЙ  ТУГОУХОСТЬЮ</article-title><trans-title-group xml:lang="en"><trans-title>EFFECTIVENESS OF COMPLEX THERAPY OF PATIENTS WITH ACUTE SENSONEURAL OBTUSITY THE EFFICIENCY OF COMPLEX TREATMENT OF PATIENTS WITH ACUTE SENSORINEURAL HEARING LOSS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никифорова</surname><given-names>Г. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikiforova</surname><given-names>G. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук,  профессор</p></bio><bio xml:lang="en"><p>MD, Prof.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Славский</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Slavskiy</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук</p></bio><bio xml:lang="en"><p>PhD  in Medicine</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гергиев</surname><given-names>В. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Gergiev</surname><given-names>V. F.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Первый Московский государственный медицинский университет имени И.М. Сеченова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov First Moscow State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>12</day><month>05</month><year>2017</year></pub-date><volume>0</volume><issue>8</issue><fpage>64</fpage><lpage>67</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Никифорова Г.Н., Славский А.Н., Гергиев В.Ф., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Никифорова Г.Н., Славский А.Н., Гергиев В.Ф.</copyright-holder><copyright-holder xml:lang="en">Nikiforova G.N., Slavskiy A.N., Gergiev V.F.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/1826">https://www.med-sovet.pro/jour/article/view/1826</self-uri><abstract><p>Слух – одно из важнейших чувств человеческого  организма. Стойкое снижение слуха, на фоне которого затрудняется восприятие окружающих звуков и речевое общение, определяется термином «тугоухость». Наиболее сложной и значимой представляется проблема острой и внезапной сенсоневральной тугоухости.  Причинами развития острых нарушений звуковосприятия могут быть инфекционные, иммунопатологические, физические, химические и ишемически-гипоксические факторы. Лечение острой и внезапной сенсоневральной  тугоухости рассматривают как оказание  неотложной  помощи. Золотым международным стандартом на современном этапе является использование глюкокортикостероидов. Для минимизации повреждающего действия причинных факторов развития патологического процесса, улучшения обменных процессов, восстановления функциональной активности и регенерации тканей, в том числе и нейроэпителия, больным с ОСНТ показано использование нейротропной терапии – витаминов  группы В. Наиболее эффективными  являются препараты, содержащие комплекс витаминов В1, В6 и В12. Одним из таких комбинированных  поливитаминных лекарственных средств является Нейромультивит.</p></abstract><trans-abstract xml:lang="en"><p>Hearing – one of the most important feelings of a human body. Permanent decrease in hearing against the background of which perception of environmental sounds and speech communication is at a loss, a bradyacuasia is defined by the term. And the problem of a sharp and sudden sensonevralny bradyacuasia is represented to the most composite significant. Can be the reasons of development  of sharp violations of sound perception infectious, immunopathological, physical, chemical and ischemichypoxemic factors. Treatment of a sharp and sudden sensonevralny bradyacuasia is considered as rendering an emergency aid. The gold international standard at the present stage is use of glucocorticosteroids. For minimization  of the damaging action of causal factors of development of pathological process, improvement of exchange processes, restitution of the functional activity and an angenesis including a neuroepithelium, use of neurotropic therapy-group B vitamins is shown to patients with sharp sensonevralny bradyacuasia. The most efficient are the medicines containing a complex of B1, B6 and B12 vitamins, one of such combined polyvitaminic pharmaceuticals is Neyromultivit.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>слуховая функция</kwd><kwd>острая сенсоневральная тугоухость</kwd><kwd>глюкокортикостероидная терапия</kwd><kwd>нейротропная терапия</kwd><kwd>витамины группы В</kwd><kwd>Нейромультивит</kwd></kwd-group><kwd-group xml:lang="en"><kwd>аcoustical function</kwd><kwd>sharp sensonevralny bradyacuasia</kwd><kwd>glucocorticosteroid therapy</kwd><kwd>neurotropic therapy</kwd><kwd>vitamins of group B</kwd><kwd>Neyromultivit</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бакулина Л.С., Машкова Т.А. Сенсоневральная тугоухость: этиология, терапия и реабилитация. Современные проблемы физиологии и патологии слуха: матер. 2-го Национального конгресса аудиологов и 6-го Международного симпозиума. Суздаль, 2007: 44-45.</mixed-citation><mixed-citation xml:lang="en">Бакулина Л.С., Машкова Т.А. Сенсоневральная тугоухость: этиология, терапия и реабилитация. Современные проблемы физиологии и патологии слуха: матер. 2-го Национального конгресса аудиологов и 6-го Международного симпозиума. Суздаль, 2007: 44-45.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. Fact Sheet №.300: Deafness and hearing impairment, 2015. Available from: http://www.who.int/mediacentre/factsheets/ fs300/en/</mixed-citation><mixed-citation xml:lang="en">World Health Organization. Fact Sheet №.300: Deafness and hearing impairment, 2015. Available from: http://www.who.int/mediacentre/factsheets/ fs300/en/</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Беличева Э.Г. Острая и внезапная сенсоневральная тугоухость: этиология, клиника, диагностика, эффективность ранней этиопатогенетической терапии: Дис. ... д-ра мед. наук: СПб. 2008. 236 c.</mixed-citation><mixed-citation xml:lang="en">Беличева Э.Г. Острая и внезапная сенсоневральная тугоухость: этиология, клиника, диагностика, эффективность ранней этиопатогенетической терапии: Дис. ... д-ра мед. наук: СПб. 2008. 236 c.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Загорянская М.Е., Румянцева М.Г. Значение эпидемиологических методов исследования в профилактике нарушения слуха у детей. Рос. оторинолар., 2003, 6(3): 79-83.</mixed-citation><mixed-citation xml:lang="en">Загорянская М.Е., Румянцева М.Г. Значение эпидемиологических методов исследования в профилактике нарушения слуха у детей. Рос. оторинолар., 2003, 6(3): 79-83.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Иванец И.В. Острая и внезапная нейросенсорная тугоухость (клиникоэкспериментальные исследования): Автореф. дис... д-ра мед. М., 2001. 42 с.</mixed-citation><mixed-citation xml:lang="en">Иванец И.В. Острая и внезапная нейросенсорная тугоухость (клиникоэкспериментальные исследования): Автореф. дис... д-ра мед. М., 2001. 42 с.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Глухота и потеря слуха. Информационный бюллетень ВОЗ. №300. Март 2015 г. http://www.who.int/mediacentre/factsheets/fs300/en/.</mixed-citation><mixed-citation xml:lang="en">Глухота и потеря слуха. Информационный бюллетень ВОЗ. №300. Март 2015 г. http://www.who.int/mediacentre/factsheets/fs300/en/.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hughes GB, Freedman MA, Haberkamp TJ et al. Sudden sensorineural hearing loss. Otolaryngol Clin North Am, 1996, 29(3): 393-404.</mixed-citation><mixed-citation xml:lang="en">Hughes GB, Freedman MA, Haberkamp TJ et al. Sudden sensorineural hearing loss. Otolaryngol Clin North Am, 1996, 29(3): 393-404.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Fetterman BL, Saunders JE, Luxford WM. Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol, 1996, 17: 529-36.</mixed-citation><mixed-citation xml:lang="en">Fetterman BL, Saunders JE, Luxford WM. Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol, 1996, 17: 529-36.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Jaffe B. Clinical studies in sudden deafness. Adv Otorhinolaryngol, 1973, 20: 221-8.</mixed-citation><mixed-citation xml:lang="en">Jaffe B. Clinical studies in sudden deafness. Adv Otorhinolaryngol, 1973, 20: 221-8.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Шидловская Т.В. Шидловская Т.Ф. Комплексное лечение сенсоневральной тугоухости. Российская оториноларингология (приложение), 2007: 700-705.</mixed-citation><mixed-citation xml:lang="en">Шидловская Т.В. Шидловская Т.Ф. Комплексное лечение сенсоневральной тугоухости. Российская оториноларингология (приложение), 2007: 700-705.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol, 1977, 86(4 pt 1): 463-480.</mixed-citation><mixed-citation xml:lang="en">Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol, 1977, 86(4 pt 1): 463-480.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss, II: a meta-analysis. Arch Otolaryngol Head Neck Surg, 2007, 133(6): 582-586.</mixed-citation><mixed-citation xml:lang="en">Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss, II: a meta-analysis. Arch Otolaryngol Head Neck Surg, 2007, 133(6): 582-586.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Журавский Г. Сенсоневральная тугоухость: молекулярно-генетические, структурные и лечебнопрофилактические аспекты (клинико-экспериментальное исследование): Автореф. дис... д-ра мед.наук. СПб., 2001. 35 с.</mixed-citation><mixed-citation xml:lang="en">Журавский Г. Сенсоневральная тугоухость: молекулярно-генетические, структурные и лечебнопрофилактические аспекты (клинико-экспериментальное исследование): Автореф. дис... д-ра мед.наук. СПб., 2001. 35 с.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Пальчун В.Т., Сагалович Б.М. Острая и внезапная нейросенсорная тугоухость. Вестник оторинолар., 1994, 5: 5-12.</mixed-citation><mixed-citation xml:lang="en">Пальчун В.Т., Сагалович Б.М. Острая и внезапная нейросенсорная тугоухость. Вестник оторинолар., 1994, 5: 5-12.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss: A double-blind clinical study. Arch Otolaryngol, 1980, 106: 772-6.</mixed-citation><mixed-citation xml:lang="en">Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss: A double-blind clinical study. Arch Otolaryngol, 1980, 106: 772-6.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Stokroos RJ, Albers F, Schirm J. The etiology of idiopathic sudden sensorineural hearing loss: experimental herpes simplex virus infection of the inner ear. Am J Otol, 1998, 19: 447-52.</mixed-citation><mixed-citation xml:lang="en">Stokroos RJ, Albers F, Schirm J. The etiology of idiopathic sudden sensorineural hearing loss: experimental herpes simplex virus infection of the inner ear. Am J Otol, 1998, 19: 447-52.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Shirwany NA, Seidman MD, Tang W. Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. Am J Otol, 1998, 19: 230-5.</mixed-citation><mixed-citation xml:lang="en">Shirwany NA, Seidman MD, Tang W. Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. Am J Otol, 1998, 19: 230-5.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Wei BP, Mubiru S, O’Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev, 2006, 1: CD003998.</mixed-citation><mixed-citation xml:lang="en">Wei BP, Mubiru S, O’Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev, 2006, 1: CD003998.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Labus J, Breil J, Stutzer H, Michel O. Meta-analysis for the effect of medical therapy vs. placebo on recovery of idiopathic sudden hearing loss. Laryngoscope, 2010, 120(9): 1863-1871.</mixed-citation><mixed-citation xml:lang="en">Labus J, Breil J, Stutzer H, Michel O. Meta-analysis for the effect of medical therapy vs. placebo on recovery of idiopathic sudden hearing loss. Laryngoscope, 2010, 120(9): 1863-1871.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss, I: a systematic review. Arch Otolaryngol Head Neck Surg, 2007, 133(6): 573-581.</mixed-citation><mixed-citation xml:lang="en">Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss, I: a systematic review. Arch Otolaryngol Head Neck Surg, 2007, 133(6): 573-581.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Slattery WH, Fisher LM, Iqbal Z, Friedman RA, Liu N. Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg, 2005, 133(2): 251-259.</mixed-citation><mixed-citation xml:lang="en">Slattery WH, Fisher LM, Iqbal Z, Friedman RA, Liu N. Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg, 2005, 133(2): 251-259.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Megighian D, Bolzan M, Barion U, Nicolai P. Epidemiological considerations in sudden hearing loss: a study of 183 cases. Arch Otorhinolaryngol, 1986, 243(4): 250-253.</mixed-citation><mixed-citation xml:lang="en">Megighian D, Bolzan M, Barion U, Nicolai P. Epidemiological considerations in sudden hearing loss: a study of 183 cases. Arch Otorhinolaryngol, 1986, 243(4): 250-253.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope, 1999, 109(7, pt 2): 1-17.</mixed-citation><mixed-citation xml:lang="en">Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope, 1999, 109(7, pt 2): 1-17.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Banerjee A, Parnes LS. Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol, 2005, 26(5): 878-881.</mixed-citation><mixed-citation xml:lang="en">Banerjee A, Parnes LS. Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol, 2005, 26(5): 878-881.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Fitzgerald D.C., McGuire J.F. Intratympanic steroids for idiopathic sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 2007, 116(4): 253-256.</mixed-citation><mixed-citation xml:lang="en">Fitzgerald D.C., McGuire J.F. Intratympanic steroids for idiopathic sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 2007, 116(4): 253-256.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Cvorovic L, Deric D, Probst R, Hegemann S. Prognostic model for predicting hearing recovery in idiopathic sudden sensorineural hearing loss. Otol Neurotol, 2008, 29(4): 464-469.</mixed-citation><mixed-citation xml:lang="en">Cvorovic L, Deric D, Probst R, Hegemann S. Prognostic model for predicting hearing recovery in idiopathic sudden sensorineural hearing loss. Otol Neurotol, 2008, 29(4): 464-469.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Powell-Tuck J, Bown RL, Lennard-Jones JE. A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol, 1978, 13(7): 833-837.</mixed-citation><mixed-citation xml:lang="en">Powell-Tuck J, Bown RL, Lennard-Jones JE. A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol, 1978, 13(7): 833-837.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Rauch SD. Clinical practice: idiopathic sudden sensorineural hearing loss. N Engl J Med, 2008, 359(8): 833-840.</mixed-citation><mixed-citation xml:lang="en">Rauch SD. Clinical practice: idiopathic sudden sensorineural hearing loss. N Engl J Med, 2008, 359(8): 833-840.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Swartz SL, Dluhy RG. Corticosteroids: clinical pharmacology and therapeutic use. Drugs, 1978, 16(3): 238-255.</mixed-citation><mixed-citation xml:lang="en">Swartz SL, Dluhy RG. Corticosteroids: clinical pharmacology and therapeutic use. Drugs, 1978, 16(3): 238-255.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Holland EG, Taylor AT. Glucocorticoids in clinical practice. J Fam Pract, 1991, 32(5): 512-519</mixed-citation><mixed-citation xml:lang="en">Holland EG, Taylor AT. Glucocorticoids in clinical practice. J Fam Pract, 1991, 32(5): 512-519</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Nash JJ, Nash AG, Leach ME, Poetker DM. Medical malpractice and corticosteroid use. Otolaryngol Head Neck Surg, 2011, 144(1): 10-15.</mixed-citation><mixed-citation xml:lang="en">Nash JJ, Nash AG, Leach ME, Poetker DM. Medical malpractice and corticosteroid use. Otolaryngol Head Neck Surg, 2011, 144(1): 10-15.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Alexander TH, Weisman MH, Derebery JM et al. Safety of high-dose corticosteroids for the treatment of autoimmune inner ear disease. Otol Neurotol, 2009, 30(4): 443-448.</mixed-citation><mixed-citation xml:lang="en">Alexander TH, Weisman MH, Derebery JM et al. Safety of high-dose corticosteroids for the treatment of autoimmune inner ear disease. Otol Neurotol, 2009, 30(4): 443-448.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Methylprednisolone: drug information. http:// www.uptodate.com/contents/methylprednisolonedrug-information. Accessed May 15, 2011.</mixed-citation><mixed-citation xml:lang="en">Methylprednisolone: drug information. http:// www.uptodate.com/contents/methylprednisolonedrug-information. Accessed May 15, 2011.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Saag KG, Furst DE. Major side effects of systemic glucocorticords. http://www.uptodate.com/contents/major-side-effectsof-systemic-glucocorticoids Title=1~150. Accessed May 18, 2011.</mixed-citation><mixed-citation xml:lang="en">Saag KG, Furst DE. Major side effects of systemic glucocorticords. http://www.uptodate.com/contents/major-side-effectsof-systemic-glucocorticoids Title=1~150. Accessed May 18, 2011.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Chandrasekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol, 2001, 22(1): 18-23.</mixed-citation><mixed-citation xml:lang="en">Chandrasekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol, 2001, 22(1): 18-23.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol, 2008, 29(4): 453-460.</mixed-citation><mixed-citation xml:lang="en">Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol, 2008, 29(4): 453-460.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Ahn JH, Yoo MH, Yoon TH, Chung JW. Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness? Laryngoscope, 2008, 118(2): 279-282.</mixed-citation><mixed-citation xml:lang="en">Ahn JH, Yoo MH, Yoon TH, Chung JW. Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness? Laryngoscope, 2008, 118(2): 279-282.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Haynes DS, O’Malley M, Cohen S, Watford K, Labadie RF. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope, 2007, 117(1): 3-15.</mixed-citation><mixed-citation xml:lang="en">Haynes DS, O’Malley M, Cohen S, Watford K, Labadie RF. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope, 2007, 117(1): 3-15.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Nezamoddin Berjis, Saeed Soheilipour, Alireza Musavi, Seyed Mostafa Hashemi. Intratympanic dexamethasone injection vs methylprednisolone for the treatment of refractory sudden sensorineural hearing loss. Advanced Biomedical Research, 2016, 1-5.</mixed-citation><mixed-citation xml:lang="en">Nezamoddin Berjis, Saeed Soheilipour, Alireza Musavi, Seyed Mostafa Hashemi. Intratympanic dexamethasone injection vs methylprednisolone for the treatment of refractory sudden sensorineural hearing loss. Advanced Biomedical Research, 2016, 1-5.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Brian DH, Sam JM. Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss. Otolaryngol Head Neck Surg, 2005, 132: 527-531.</mixed-citation><mixed-citation xml:lang="en">Brian DH, Sam JM. Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss. Otolaryngol Head Neck Surg, 2005, 132: 527-531.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Hu A, Parnes LS. Intratympanic steroids for inner ear disorders: a review. Audiol Neurootol, 2009, 14(6): 373-382. Doyle K.J., Bauch C., Battista R., et al. Intratympanic steroid treatment: a review. Otol Neurotol. 2004, 25(6): 1034-1039.</mixed-citation><mixed-citation xml:lang="en">Hu A, Parnes LS. Intratympanic steroids for inner ear disorders: a review. Audiol Neurootol, 2009, 14(6): 373-382. Doyle K.J., Bauch C., Battista R., et al. Intratympanic steroid treatment: a review. Otol Neurotol. 2004, 25(6): 1034-1039.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Alles MJ, der Gaag MA, Stokroos RJ. Intratympanic steroid therapy for inner ear diseases, a review of the literature. Eur Arch Otorhinolaryngol, 2006, 263(9): 791-797.</mixed-citation><mixed-citation xml:lang="en">Alles MJ, der Gaag MA, Stokroos RJ. Intratympanic steroid therapy for inner ear diseases, a review of the literature. Eur Arch Otorhinolaryngol, 2006, 263(9): 791-797.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Hoffer ME, Balough BJ, Gottshall KR. Delivery of drugs to the inner ear. Curr Opin Otolaryngol Head Neck Surg, 2006, 14(5): 329-331.</mixed-citation><mixed-citation xml:lang="en">Hoffer ME, Balough BJ, Gottshall KR. Delivery of drugs to the inner ear. Curr Opin Otolaryngol Head Neck Surg, 2006, 14(5): 329-331.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Bettendorff L, Kolb HA, Schoffeniels E. Thiamine triphosphate activates anion channels of large unit conductance in neuroblastoma cells. J. Membr. Biol., 1993, 136: 281-288.</mixed-citation><mixed-citation xml:lang="en">Bettendorff L, Kolb HA, Schoffeniels E. Thiamine triphosphate activates anion channels of large unit conductance in neuroblastoma cells. J. Membr. Biol., 1993, 136: 281-288.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Bâ A. Metabolic and structural role of thiamine in nervous tissues. Cell. Mol. Neurobiol., 2008 Nov, 28(7): 923-31.</mixed-citation><mixed-citation xml:lang="en">Bâ A. Metabolic and structural role of thiamine in nervous tissues. Cell. Mol. Neurobiol., 2008 Nov, 28(7): 923-31.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Горбачев В.В., Горбачева В.Н. Витамины, микрои макроэлементы: Справочник. Мн.: Книжный дом: Интерпрессервис, 2002. 544 с.</mixed-citation><mixed-citation xml:lang="en">Горбачев В.В., Горбачева В.Н. Витамины, микрои макроэлементы: Справочник. Мн.: Книжный дом: Интерпрессервис, 2002. 544 с.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Wilson RG, Davis RE. Clinical chemistry of vitamin B6. Adv. Clin. Chem., 1983, 23: 1-68.</mixed-citation><mixed-citation xml:lang="en">Wilson RG, Davis RE. Clinical chemistry of vitamin B6. Adv. Clin. Chem., 1983, 23: 1-68.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">He K, Merchant A, Rimm EB, Rosner BA, Stampfer MJ, Willett WC, Ascherio A. Folate, Vitamin B6, and B12 Intakes in Relation to Risk of Stroke Among Men. Stroke, 2004: 35-169.</mixed-citation><mixed-citation xml:lang="en">He K, Merchant A, Rimm EB, Rosner BA, Stampfer MJ, Willett WC, Ascherio A. Folate, Vitamin B6, and B12 Intakes in Relation to Risk of Stroke Among Men. Stroke, 2004: 35-169.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Diaz DE, Tuesta AM, Ribo MD, Belinchon O, Marchena PJ, Bruscas MJ, Val E, Cortes A, Nieto JA. Low levels of vitamin B 12 and venous thromboembolic disease in elderly men. J. Intern. Med., 2005 Sep, 258(3): 244-9.</mixed-citation><mixed-citation xml:lang="en">Diaz DE, Tuesta AM, Ribo MD, Belinchon O, Marchena PJ, Bruscas MJ, Val E, Cortes A, Nieto JA. Low levels of vitamin B 12 and venous thromboembolic disease in elderly men. J. Intern. Med., 2005 Sep, 258(3): 244-9.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Киричек Л.Т. Фармакология витаминов. Международный медицинский журнал, 2001, 7(4): 97-104.</mixed-citation><mixed-citation xml:lang="en">Киричек Л.Т. Фармакология витаминов. Международный медицинский журнал, 2001, 7(4): 97-104.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Нейромультивит. Инструкция по применению: http://www.rlsnet.ru/tn_index_id_1643.htm.</mixed-citation><mixed-citation xml:lang="en">Нейромультивит. Инструкция по применению: http://www.rlsnet.ru/tn_index_id_1643.htm.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Козелкин А.А., Кузнецов А.А., Медведкова С.А. Применение нейромультивита в неврологической практике. Therapia, 2008, 11(31): 1-5.</mixed-citation><mixed-citation xml:lang="en">Козелкин А.А., Кузнецов А.А., Медведкова С.А. Применение нейромультивита в неврологической практике. Therapia, 2008, 11(31): 1-5.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Жиров И.В., Федина М.А., Покровский А.Б. Опыт применения препарата Нейромультивит при алкогольной полинейропатии. Новые лекарственные препараты, 2002, 12: 10-18.</mixed-citation><mixed-citation xml:lang="en">Жиров И.В., Федина М.А., Покровский А.Б. Опыт применения препарата Нейромультивит при алкогольной полинейропатии. Новые лекарственные препараты, 2002, 12: 10-18.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Гуревич К.Г. Нейромультивит: применение в современной практике. Фарматека, 2004, 9-10: 48-51.</mixed-citation><mixed-citation xml:lang="en">Гуревич К.Г. Нейромультивит: применение в современной практике. Фарматека, 2004, 9-10: 48-51.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Токмакова А.Ю. Анциферов М.Б. Возможности использования Нейромультивита в комплексной терапии полинейропатии у больных сахарным диабетом. Сахарный диабет, 2001, 11(2): 33-35.</mixed-citation><mixed-citation xml:lang="en">Токмакова А.Ю. Анциферов М.Б. Возможности использования Нейромультивита в комплексной терапии полинейропатии у больных сахарным диабетом. Сахарный диабет, 2001, 11(2): 33-35.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Бреговский В.Б., Белогурова Е.В., Кузьмина В.А. Применение Нейромультивита у больных с хронической формой диабетической сенсомоторной полинейропатией нижних конечностей. Новые лекарственные препараты, 2002, 6: 7-10.</mixed-citation><mixed-citation xml:lang="en">Бреговский В.Б., Белогурова Е.В., Кузьмина В.А. Применение Нейромультивита у больных с хронической формой диабетической сенсомоторной полинейропатией нижних конечностей. Новые лекарственные препараты, 2002, 6: 7-10.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Шавловская О.А. Витамины группы В в неврологической практике. РМЖ, 2013, 30: 1582-1585.</mixed-citation><mixed-citation xml:lang="en">Шавловская О.А. Витамины группы В в неврологической практике. РМЖ, 2013, 30: 1582-1585.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
